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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of health claims related to 
sugar-free chewing gum with calcium phosphoryl oligosaccharides and 
maintenance of tooth mineralisation (ID 337) pursuant to Article 13(1) of 
Regulation (EC) No 1924/2006
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2,
 
3
 
European Food Safety Authority (EFSA), Parma, Italy 
SUMMARY 
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and 
Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of 
Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims 
in relation to sugar-free chewing gum with calcium phosphoryl oligosaccharides and maintenance of 
tooth mineralisation. The scientific substantiation is based on the information provided by the 
Member States in the consolidated list of Article 13 health claims and references that EFSA has 
received from Member States or directly from stakeholders. 
The food constituent that is the subject of the health claim is calcium phosphoryl oligosaccharides. In 
the context of the references provided, the Panel assumes that the food, which is the subject of the 
health claim is sugar-free chewing gum with calcium phosphoryl oligosaccharides. From the 
references provided, the Panel assumes that the claim refers to an effect of sugar-free chewing gum 
with calcium phosphoryl oligosaccharides on maintenance of tooth mineralisation beyond the well 
established effect that other sugar-free chewing gums (i.e. without calcium phosphoryl 
oligosaccharides) have on tooth mineralisation. The Panel considers that the food, sugar-free chewing 
gum with calcium phosphoryl oligosaccharides, which is the subject of the health claim and the 
comparison food, sugar-free chewing gum without calcium phosphoryl oligosaccharides, are both 
sufficiently characterised in relation to the claimed effect. 
The claimed effect is “dental health”. The target population is assumed to be the general population. 
In the context of the proposed wordings, the Panel assumes that the claimed effect refers to a 
beneficial balance between de- and remineralisation of tooth enamel and dentin. The Panel considers 
that maintenance of tooth mineralisation is a beneficial physiological effect.  
                                                     
1  On request from the European Commission, Question No EFSA-Q-2008-1124, adopted on 08 April 2011. 
2  Panel members: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, 
Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, 
Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, 
Hendrik van Loveren and Hans Verhagen. Correspondence: nda@efsa.europa.eu 
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Heinonen, Hannu Korhonen, Martinus Løvik, Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, 
Sean (J.J.) Strain, Inge Tetens, Hendrik van Loveren and Hans Verhagen.  
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No human studies were provided from which conclusions can be drawn for the scientific 
substantiation of the claim. 
The Panel concludes that a cause and effect relationship has not been established between the use of 
sugar-free chewing gum with calcium phosphoryl oligosaccharides and maintenance of tooth 
mineralisation over and above the well established role of sugar-free chewing gum on the 
maintenance of tooth mineralisation. 
A claim on sugar-free chewing gum and maintenance of tooth mineralisation has already been 
assessed with a favourable outcome. 
KEY WORDS 
Sugar-free, chewing gum, calcium phosphoryl oligosaccharides, tooth mineralisation, health claims. 
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INFORMATION AS PROVIDED IN THE CONSOLIDATED LIST 
The consolidated list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006
4
 
submitted by Member States contains main entry claims with corresponding conditions of use and 
literature for similar health claims. EFSA has screened all health claims contained in the original 
consolidated list of Article 13 health claims which was received by EFSA in 2008 using six criteria 
established by the NDA Panel to identify claims for which EFSA considered sufficient information 
had been provided for evaluation and those for which more information or clarification was needed 
before evaluation could be carried out
5
. The clarifications which were received by EFSA through the 
screening process have been included in the consolidated list. This additional information will serve 
as clarification to the originally provided information. The information provided in the consolidated 
list for the health claims which are the subject of this opinion is tabulated in Appendix C.  
ASSESSMENT 
1. Characterisation of the food/constituent (ID 337) 
The food constituent that is the subject of the health claim is calcium phosphoryl oligosaccharides. 
In the context of the references provided, the Panel assumes that the food, which is the subject of the 
health claim, is sugar-free chewing gum with calcium phosphoryl oligosaccharides. 
The composition of the gum, i.e. gum base and sweetening agent, is unspecified. The characteristic 
components of chewing gums are the gum base, which may comprise a complex mixture of 
elastomers, natural and synthetic resins, fats, emulsifiers, waxes, antioxidants, and filler, together with 
sweetening and flavouring agents (Imfeld, 1999; Rassing, 1996). The common characteristic of 
sugar-free chewing gums is the absence of fermentable carbohydrates (Edgar, 1998; Ly et al., 2008). 
The ingredients are well characterised, can be measured by established methods, and the principles of 
the manufacturing process have been described (Rassing, 1996). Many of the ingredients in the gum 
base and most sweetening agents used in sugar-free chewing gums occur naturally in foods. 
The phosphoryl oligosaccharides (POs) in the sugar-free chewing gum that is the subject of the claim 
are produced from potato starch using bacterial liquefying α-amylase (EC 3.2.1.1), glucoamylase 
(EC 3.2.1.3) and pullulanase (EC 3.2.1.41). Fraction PO-1 is the major component of the POs and is 
composed of maltotriose, maltotetraose and maltopentaose to which one phosphoryl group is attached. 
Fraction PO-2 is predominantly composed of maltopentaose and maltohexaose to which at least two 
phosphoryl groups are attached. The average degree of polymerisation of dephosphorylated PO-1 and 
PO-2 is 4.02 and 5.82, respectively (Kamasaka et al., 2003). From the references provided, the Panel 
assumes that the POs in the sugar-free chewing gum that is the subject of the claim contain 
5 w% calcium and are added to chewing gum in concentrations of 2.45-2.60 % (Inaba et al., 2002a; 
Inaba et al., 2002b; Inaba et al., 2003; Kamasaka et al., 2002).  
A claim on sugar-free chewing gum and maintenance of tooth mineralisation has already been 
assessed with a favourable outcome (EFSA Panel on Dietetic Products Nutrition and Allergies 
(NDA), 2009).  
From the references provided, the Panel assumes that the claim refers to an effect of sugar-free 
chewing gum with calcium phosphoryl oligosaccharides (Ca-POs) on maintenance of tooth 
                                                     
4  Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25.  
5  EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2011. General guidance for stakeholders on the 
evaluation of Article 13.1, 13.5 and 14 health claims. EFSA Journal, 9(4):2135, 24 pp. 
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mineralisation beyond the well established effect that other sugar-free chewing gums (i.e. without 
calcium phosphoryl oligosaccharides) have on tooth mineralisation. 
The Panel considers that the food, sugar-free chewing gum with calcium phosphoryl oligosaccharides, 
which is the subject of the health claim, and the comparison food, sugar-free chewing gum without 
calcium phosphoryl oligosaccharides, are both sufficiently characterised in relation to the claimed 
effect. 
2. Relevance of the claimed effect to human health (ID 337) 
The claimed effect is “dental health”. The Panel assumes that the target population is the general 
population.  
In the context of the proposed wordings, the Panel assumes that the claimed effect refers to a 
beneficial balance between de- and remineralisation of tooth enamel and dentin.  
The Panel considers that maintenance of tooth mineralisation is a beneficial physiological effect.  
3. Scientific substantiation of the claimed effect (ID 337) 
Among the references provided were three reviews on the production and application of calcium 
phosphoryl oligosaccharides, one company request on the possible novel food status of calcium 
phosphoryl oligosaccharides and the subsequent reply of the national Competent Authority, all of 
which did not contain any original data which could be used for the scientific substantiation of the 
claim. The Panel considers that no conclusions can be drawn from these references for the scientific 
substantiation of the claim. 
Three human in situ studies were provided which investigated the effect of sugar-free chewing gum 
with calcium phosphoryl oligosaccharides on enamel or dentin remineralisation. 
In all three studies the enamel and dentin disks used were cut from the crown parts of bovine incisors 
and artificial caries-like lesions were produced by immersing the disks for two (Inaba et al., 2002a) or 
three weeks (Inaba et al., 2002b; Inaba et al., 2003) in a 0.1 M lactic acid gel containing 6 w% 
carboxymethylcellulose. The demineralised disks were kept in the oral cavity for the duration of 
chewing plus an additional time equal to the chewing time in the respective study. They were then 
removed and stored in a container with 100 % humidity. Lesion depths and mineral loss values were 
measured by microradiography.  
Two of the intervention studies were conducted in a double-blind, cross-over manner (Inaba et al., 
2002a; Inaba et al., 2003) and one used a double-blind, parallel design (Inaba et al., 2002b). In each 
trial, 12 healthy adult volunteers (mean age 21 and 22 years) were recruited. Each volunteer wore a 
palatal appliance containing demineralised enamel (Inaba et al., 2002b; Inaba et al., 2003) or 
demineralised enamel and dentin (Inaba et al., 2002a) disks. In the cross-over study by Inaba et al. 
(2002a) subjects chewed sugar-free chewing gum containing 48.5 % xylitol and sugar-free chewing 
gum containing 46 % xylitol plus 2.6 % Ca-POs four times a day for ten minutes for two weeks each. 
The design of the cross-over study by Inaba et al. (2003) was similar but included an additional period 
with a chewing gum containing 62 % sucrose and the test chewing gum only contained 2.45 % 
Ca-POs. In the parallel design study by Inaba et al. (2002b) subjects were randomised to use 
sugar-free chewing gum containing 47.5 % xylitol, sugar-free chewing gum containing 45 % xylitol 
plus 2.5 % Ca-POs, or a chewing gum containing 62 % sucrose four times a day for 20 minutes for 
four weeks.  
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The Panel notes that in all of the studies enamel and dentin disks were only worn during the time of 
gum-chewing plus a period equal to the chewing time and that this study design is not appropriate to 
assess a balance between de- and remineralisation of tooth enamel and dentin in normal eating 
conditions. The Panel considers that no conclusions can be drawn from these studies for the scientific 
substantiation of the claim. 
Two in vitro studies addressed the effect of calcium phosphoryl oligosaccharides on remineralisation 
of enamel (Inaba et al., 2002c; Kamasaka et al., 2002). The Panel considers that evidence provided in 
in vitro studies is not sufficient to predict an effect of the use of sugar-free chewing gum with calcium 
phosphoryl oligosaccharides on maintenance of tooth mineralisation in vivo in humans.  
The Panel concludes that a cause and effect relationship has not been established between the use of 
sugar-free chewing gum with calcium phosphoryl oligosaccharides and maintenance of tooth 
mineralisation over and above the well established role of sugar-free chewing gum on the 
maintenance of tooth mineralisation. 
A claim on sugar-free chewing gum and maintenance of tooth mineralisation has already been 
assessed with a favourable outcome (EFSA Panel on Dietetic Products Nutrition and Allergies 
(NDA), 2009).  
CONCLUSIONS 
On the basis of the data presented, the Panel concludes that: 
 The food, sugar-free chewing gum with calcium phosphoryl oligosaccharides, which is the 
subject of the health claim, and the comparison food, sugar-free chewing gum without 
calcium phosphoryl oligosaccharides, are both sufficiently characterised in relation to the 
claimed effect.  
 The claimed effect is “dental health”. The target population is assumed to be the general 
population. In the context of the proposed wordings, it is assumed that the claimed effect 
refers to a beneficial balance between de- and remineralisation of tooth enamel and dentin. 
Maintenance of tooth mineralisation is a beneficial physiological effect. 
 A cause and effect relationship has not been established between the use of sugar-free 
chewing gum with calcium phosphoryl oligosaccharides and maintenance of tooth 
mineralisation over and above the well established role of sugar-free chewing gum on the 
maintenance of tooth mineralisation. 
 A claim on sugar-free chewing gum and maintenance of tooth mineralisation has already been 
assessed with a favourable outcome. 
DOCUMENTATION PROVIDED TO EFSA 
Health claims pursuant to Article 13 of Regulation (EC) No 1924/2006 (No: EFSA-Q-2008-1124). 
The scientific substantiation is based on the information provided by the Member States in the 
consolidated list of Article 13 health claims and references that EFSA has received from Member 
States or directly from stakeholders. 
The full list of supporting references as provided to EFSA is available on: 
http://www.efsa.europa.eu/panels/nda/claims/article13.htm. 
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APPENDICES 
APPENDIX A 
BACKGROUND AND TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The Regulation 1924/2006 on nutrition and health claims made on foods
6
 (hereinafter "the 
Regulation") entered into force on 19
th
 January 2007. 
Article 13 of the Regulation foresees that the Commission shall adopt a Community list of permitted 
health claims other than those referring to the reduction of disease risk and to children's development 
and health. This Community list shall be adopted through the Regulatory Committee procedure and 
following consultation of the European Food Safety Authority (EFSA). 
Health claims are defined as "any claim that states, suggests or implies that a relationship exists 
between a food category, a food or one of its constituents and health". 
In accordance with Article 13 (1) health claims other than those referring to the reduction of disease 
risk and to children's development and health are health claims describing or referring to:  
a) the role of a nutrient or other substance in growth, development and the functions of the 
body; or 
b) psychological and behavioural functions; or 
c) without prejudice to Directive 96/8/EC, slimming or weight-control or a reduction in the 
sense of hunger or an increase in the sense of satiety or to the reduction of the available 
energy from the diet. 
To be included in the Community list of permitted health claims, the claims shall be: 
(i) based on generally accepted scientific evidence; and 
(ii) well understood by the average consumer. 
Member States provided the Commission with lists of claims as referred to in Article 13 (1) by 31 
January 2008 accompanied by the conditions applying to them and by references to the relevant 
scientific justification. These lists have been consolidated into the list which forms the basis for the 
EFSA consultation in accordance with Article 13 (3). 
ISSUES THAT NEED TO BE CONSIDERED 
IMPORTANCE AND PERTINENCE OF THE FOOD
7
  
Foods are commonly involved in many different functions
8
 of the body, and for one single food many 
health claims may therefore be scientifically true. Therefore, the relative importance of food e.g. 
nutrients in relation to other nutrients for the expressed beneficial effect should be considered: for 
functions affected by a large number of dietary factors it should be considered whether a reference to 
a single food is scientifically pertinent. 
                                                     
6 OJ L12, 18/01/2007 
7 The term 'food' when used in this Terms of Reference refers to a food constituent, the food or the food category.  
8 The term 'function' when used in this Terms of Reference refers to health claims in Article 13(1)(a), (b) and (c).  
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It should also be considered if the information on the characteristics of the food contains aspects 
pertinent to the beneficial effect. 
SUBSTANTIATION OF CLAIMS BY GENERALLY ACCEPTABLE SCIENTIFIC EVIDENCE 
Scientific substantiation is the main aspect to be taken into account to authorise health claims. Claims 
should be scientifically substantiated by taking into account the totality of the available scientific 
data, and by weighing the evidence, and shall demonstrate the extent to which: 
(a) the claimed effect of the food is beneficial for human health, 
(b) a cause and effect relationship is established between consumption of the food and the 
claimed effect in humans (such as: the strength, consistency, specificity, dose-
response, and biological plausibility of the relationship), 
(c) the quantity of the food and pattern of consumption required to obtain the claimed 
effect could reasonably be achieved as part of a balanced diet, 
(d) the specific study group(s) in which the evidence was obtained is representative of the 
target population for which the claim is intended. 
EFSA has mentioned in its scientific and technical guidance for the preparation and presentation of 
the application for authorisation of health claims consistent criteria for the potential sources of 
scientific data. Such sources may not be available for all health claims. Nevertheless it will be 
relevant and important that EFSA comments on the availability and quality of such data in order to 
allow the regulator to judge and make a risk management decision about the acceptability of health 
claims included in the submitted list. 
The scientific evidence about the role of a food on a nutritional or physiological function is not 
enough to justify the claim. The beneficial effect of the dietary intake has also to be demonstrated. 
Moreover, the beneficial effect should be significant i.e. satisfactorily demonstrate to beneficially 
affect identified functions in the body in a way which is relevant to health. Although an appreciation 
of the beneficial effect in relation to the nutritional status of the European population may be of 
interest, the presence or absence of the actual need for a nutrient or other substance with nutritional or 
physiological effect for that population should not, however, condition such considerations. 
Different types of effects can be claimed. Claims referring to the maintenance of a function may be 
distinct from claims referring to the improvement of a function. EFSA may wish to comment whether 
such different claims comply with the criteria laid down in the Regulation. 
WORDING OF HEALTH CLAIMS 
Scientific substantiation of health claims is the main aspect on which EFSA's opinion is requested. 
However, the wording of health claims should also be commented by EFSA in its opinion. 
There is potentially a plethora of expressions that may be used to convey the relationship between the 
food and the function. This may be due to commercial practices, consumer perception and linguistic 
or cultural differences across the EU. Nevertheless, the wording used to make health claims should be 
truthful, clear, reliable and useful to the consumer in choosing a healthy diet. 
In addition to fulfilling the general principles and conditions of the Regulation laid down in Article 3 
and 5, Article 13(1)(a) stipulates that health claims shall describe or refer to "the role of a nutrient or 
other substance in growth, development and the functions of the body". Therefore, the requirement to 
Sugar-free chewing gum with calcium phosphoryl oligosaccharides and  
maintenance of tooth mineralisation 
 
11 EFSA Journal 2011;9(6):2267 
describe or refer to the 'role' of a nutrient or substance in growth, development and the functions of 
the body should be carefully considered. 
The specificity of the wording is very important. Health claims such as "Substance X supports the 
function of the joints" may not sufficiently do so, whereas a claim such as "Substance X helps 
maintain the flexibility of the joints" would. In the first example of a claim it is unclear which of the 
various functions of the joints is described or referred to contrary to the latter example which 
specifies this by using the word "flexibility". 
The clarity of the wording is very important. The guiding principle should be that the description or 
reference to the role of the nutrient or other substance shall be clear and unambiguous and therefore 
be specified to the extent possible i.e. descriptive words/ terms which can have multiple meanings 
should be avoided. To this end, wordings like "strengthens your natural defences" or "contain 
antioxidants" should be considered as well as "may" or "might" as opposed to words like 
"contributes", "aids" or "helps".  
In addition, for functions affected by a large number of dietary factors it should be considered 
whether wordings such as "indispensable", "necessary", "essential" and "important" reflects the 
strength of the scientific evidence. 
Similar alternative wordings as mentioned above are used for claims relating to different relationships 
between the various foods and health. It is not the intention of the regulator to adopt a detailed and 
rigid list of claims where all possible wordings for the different claims are approved. Therefore, it is 
not required that EFSA comments on each individual wording for each claim unless the wording is 
strictly pertinent to a specific claim. It would be appreciated though that EFSA may consider and 
comment generally on such elements relating to wording to ensure the compliance with the criteria 
laid down in the Regulation. 
In doing so the explanation provided for in recital 16 of the Regulation on the notion of the average 
consumer should be recalled. In addition, such assessment should take into account the particular 
perspective and/or knowledge in the target group of the claim, if such is indicated or implied. 
TERMS OF REFERENCE 
HEALTH CLAIMS OTHER THAN THOSE REFERRING TO THE REDUCTION OF DISEASE RISK AND TO 
CHILDREN'S DEVELOPMENT AND HEALTH 
EFSA should in particular consider, and provide advice on the following aspects: 
 Whether adequate information is provided on the characteristics of the food pertinent to the 
beneficial effect. 
 Whether the beneficial effect of the food on the function is substantiated by generally 
accepted scientific evidence by taking into account the totality of the available scientific data, 
and by weighing the evidence. In this context EFSA is invited to comment on the nature and 
quality of the totality of the evidence provided according to consistent criteria. 
 The specific importance of the food for the claimed effect. For functions affected by a large 
number of dietary factors whether a reference to a single food is scientifically pertinent. 
In addition, EFSA should consider the claimed effect on the function, and provide advice on the 
extent to which: 
 the claimed effect of the food in the identified function is beneficial. 
 a cause and effect relationship has been established between consumption of the food and the 
claimed effect in humans and whether the magnitude of the effect is related to the quantity 
Sugar-free chewing gum with calcium phosphoryl oligosaccharides and  
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consumed. 
 where appropriate, the effect on the function is significant in relation to the quantity of the 
food proposed to be consumed and if this quantity could reasonably be consumed as part of a 
balanced diet.  
 the specific study group(s) in which the evidence was obtained is representative of the target 
population for which the claim is intended. 
 the wordings used to express the claimed effect reflect the scientific evidence and complies 
with the criteria laid down in the Regulation.  
When considering these elements EFSA should also provide advice, when appropriate: 
 on the appropriate application of Article 10 (2) (c) and (d) in the Regulation, which provides 
for additional labelling requirements addressed to persons who should avoid using the food; 
and/or warnings for products that are likely to present a health risk if consumed to excess. 
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APPENDIX B 
EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation to the marketing 
of the food/food constituent, a positive assessment of its safety, nor a decision on whether the 
food/food constituent is, or is not, classified as foodstuffs. It should be noted that such an assessment 
is not foreseen in the framework of Regulation (EC) No 1924/2006. 
It should also be highlighted that the scope, the proposed wordings of the claims and the conditions of 
use as proposed in the Consolidated List may be subject to changes, pending the outcome of the 
authorisation procedure foreseen in Article 13(3) of Regulation (EC) No 1924/2006. 
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APPENDIX C 
Table 1. Main entry health claims related to sugar-free chewing gum with calcium phosphoryl 
oligosaccharides, including conditions of use from similar claims, as proposed in the Consolidated 
List. 
ID Food or Food constituent Health Relationship Proposed wording 
337 Calcium phosphoryl 
oligosaccharide. 
Clarification provided 
Calcium phosphoryl 
oligosaccharide isolated 
from potato starch which 
has a naturally high content 
of phosphate groups to 
which calcium is attached. 
Most relevant in the present 
context is that the product 
has a phophorus content of 
at least 3% and a calcium 
content of 5.0 - 5.5%. For 
the most part, the product 
consists of complex 
carbohydrate (from starch). 
Dental health. remineralizes/restores tooth enamel 
after meals 
increases tooth surface hardness 
helps strengthen teeth. 
Conditions of use 
- Incorporated in toothfriendly confectionery such as chewing gum candies and chocolate at 
levels of about 2 – 2.5% 
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GLOSSARY AND ABBREVIATIONS 
PO Phosphoryl oligosaccharide  
 
